SCCA Immunotherapy Trials Intake — Seattle, Washington

SCCA Immunotherapy Trials Intake is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

SCCA Immunotherapy Trials Intake has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hepatocellular Cancer, AFP Expressing Tumors.

Sponsors: Adaptimmune.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCCA Immunotherapy Trials Intake?

SCCA Immunotherapy Trials Intake has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCCA Immunotherapy Trials Intake conducted?

SCCA Immunotherapy Trials Intake has 1 clinical trials on record, with 1 currently active. Their work covers Hepatocellular Cancer, AFP Expressing Tumors.

Is SCCA Immunotherapy Trials Intake accredited by Crixeo Health?

SCCA Immunotherapy Trials Intake has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCCA Immunotherapy Trials Intake?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.